A Simple Trick to Improve Our Transradial Punctures

Transradial access is here to stay; that much has been clear for some time now. However, some operators still resist change and the systematic use of this technique shows great geographical dispersion. Some of its limitations are a difficulty to obtain access and the somewhat frequent occurrence of radial artery occlusion after the procedure. This study assessed a very simple resource to avoid artery occlusion: an injection of nitroglycerin at the puncture site.

Un truco sencillo para mejorar nuestras punciones radialesThis work included 188 patients undergoing transradial catheterization who were randomized to subcutaneous injection of 0.5 mL 0.1% nitroglycerin at the puncture site or a placebo. All patients were assessed through ultrasound examinations before and at 24 hours after the procedure.

 

Upon comparison of the radial artery diameter before and after the procedure, patients in the nitroglycerin-treated group presented a significantly greater diameter than patients in the placebo control group. Most importantly, the incidence of occlusion was substantially lower in the nitroglycerin-treated group (5.4% vs. 14.4%; p = 0.04).


Read also: Antiaggregation Time after Treating Bifurcations.


There were no significant differences in other complications (forearm hematoma, pseudoaneurysm, etc.).

 

Conclusion

Subcutaneous injection of nitroglycerin at the radial artery puncture site increases the radial artery diameter and reduces the incidence of radial artery occlusion post-catheterization.

 

Original title: Subcutaneous Injection of Nitroglycerin at the Radial Artery Puncture Site Reduces the Risk of Early Radial Artery Occlusion After Transradial Coronary Catheterization. A Randomized, Placebo-Controlled Clinical Trial.

Reference: Yequn Chen et al. Circ Cardiovasc Interv. 2018;11:e006571.

 

2018-08-31-NTG-subcutánea-full


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the available evidence, its use remains limited. AngioFFR...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...